Literature DB >> 11141056

Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.

D F Doyle1, D A Braasch, C G Simmons, B A Janowski, D R Corey.   

Abstract

Genome sequencing has revealed thousands of novel genes, placing renewed emphasis on chemical approaches for controlling gene expression. Antisense oligomers designed directly from the information generated by sequencing are one option for achieving this control. Here we explore the rules governing the inhibition of gene expression by peptide nucleic acids (PNAs) inside cells. PNAs are a DNA/RNA mimic in which the phosphate deoxyribose backbone has been replaced by uncharged linkages. Binding to complementary sequences is not hindered by electrostatic repulsion and is characterized by high rates of association and elevated affinities. Here we test the hypothesis that the favorable properties of PNAs offer advantages for recognition of mRNA and antisense inhibition of gene expression in vivo. We have targeted 27 PNAs to 18 different sites throughout the 5'-untranslated region (5'-UTR), start site, and coding regions of luciferase mRNA. PNAs were introduced into living cells in culture as PNA-DNA-lipid complexes, providing a convenient high throughput method for cellular delivery. We find that PNAs targeted to the terminus of the 5'-UTR are potent and sequence-specific antisense agents. PNAs fifteen to eighteen bases in length were optimal inhibitors. The introduction of one or two mismatches abolished inhibition, and complementary PNAs targeted to the sense strand were also inactive. In striking contrast to effective inhibition by PNAs directed to the terminal region, PNAs complementary to other sites within the 5'-UTR do not inhibit gene expression. We also observe no inhibition by PNAs complementary to the start site or rest of the coding region, nor do we detect inhibition by PNAs that are highly C/G rich and possess extremely high affinities for their target sequences. Our results suggest that PNAs can block binding of the translation machinery but are less able to block the progress of the ribosome along mRNA. The high specificity of antisense inhibition by PNAs emphasizes both the promise and the challenges for PNAs as antisense agents and provides general guidelines for using PNAs to probe the molecular recognition of biological targets inside cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141056     DOI: 10.1021/bi0020630

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  26 in total

1.  Non-Watson-Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase.

Authors:  Alan J Tackett; David R Corey; Kevin D Raney
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.

Authors:  Dwaine A Braasch; Yinghui Liu; David R Corey
Journal:  Nucleic Acids Res       Date:  2002-12-01       Impact factor: 16.971

Review 3.  The peptide nucleic acids (PNAs): introduction to a new class of probes for chromosomal investigation.

Authors:  Franck Pellestor; Petra Paulasova
Journal:  Chromosoma       Date:  2004-05-19       Impact factor: 4.316

Review 4.  PNA Technology.

Authors:  Peter E Nielsen
Journal:  Mol Biotechnol       Date:  2004-03       Impact factor: 2.695

Review 5.  Advances in therapeutic bacterial antisense biotechnology.

Authors:  John P Hegarty; David B Stewart
Journal:  Appl Microbiol Biotechnol       Date:  2017-12-05       Impact factor: 4.813

6.  Targeting Cancer Gene Dependencies with Anthrax-Mediated Delivery of Peptide Nucleic Acids.

Authors:  Zeyu Lu; Brenton R Paolella; Nicholas L Truex; Alexander R Loftis; Xiaoli Liao; Amy E Rabideau; Meredith S Brown; John Busanovich; Rameen Beroukhim; Bradley L Pentelute
Journal:  ACS Chem Biol       Date:  2020-05-11       Impact factor: 5.100

7.  Small mitochondrial-targeted RNAs modulate endogenous mitochondrial protein expression in vivo.

Authors:  Atif Towheed; Desiree M Markantone; Aaron T Crain; Alicia M Celotto; Michael J Palladino
Journal:  Neurobiol Dis       Date:  2014-05-05       Impact factor: 5.996

8.  Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli.

Authors:  Thomas R Aunins; Keesha E Erickson; Anushree Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-16       Impact factor: 11.205

9.  Steric inhibition of human immunodeficiency virus type-1 Tat-dependent trans-activation in vitro and in cells by oligonucleotides containing 2'-O-methyl G-clamp ribonucleoside analogues.

Authors:  Stephen C Holmes; Andrey A Arzumanov; Michael J Gait
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

10.  Intracellular inhibition of hepatitis C virus (HCV) internal ribosomal entry site (IRES)-dependent translation by peptide nucleic acids (PNAs) and locked nucleic acids (LNAs).

Authors:  Christopher J Nulf; David Corey
Journal:  Nucleic Acids Res       Date:  2004-07-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.